Botox battle: Allergan attempts to block sale of injectables competitor in US market with support of ITC: The US’ International Trade Commission agreed that Daewoong’s rival product, Jeuveau, was unfairly sold in the US market, however, the full details of the decision have not yet been disclosed
No comments:
Post a Comment